Risk of infection lower with SGLT2i than DPP4i

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2017卷 / 1期
关键词：
D O I：
10.1007/s40278-024-62986-3
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：10 / 10
相关论文
共 50 条
  • [31] DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney
    Samaan, Emad
    Ramadan, Nehal M.
    Abdulaziz, Hoda M. M.
    Ibrahim, Dina
    El-Sherbiny, Mohamed
    Elbayar, Rana
    Ghattas, Yasmin
    Abdlmalek, Joly
    Bayali, Omnia
    Elhusseini, Yousef
    Maghrabia, Aya
    El -Gamal, Randa
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [32] COMPARATIVE SAFETY OF SODIUM-GLUCOSE CO- TRANSPORTER-2 INHIBITORS (SGLT2I) AND DIPEPTIDYL PEPTIDASE-4 INHIBITORS (DPP4I) IN PATIENTS RECEIVING ANTI-NEOPLASTIC THERAPIES FOR CANCER
    Lyu, Jiaxuan
    Specht, Katherineht
    Seglie, Jacqueline
    Ouyang, Tianqi
    Mistry, Kavita
    Zubiri, Leyre
    Khor, Si Yuan
    Cao, Andrew
    Moreno, Daiana
    Mejia, Sherley
    Sise, Meghan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2025, 85 (04)
  • [33] Role of DPP4 and DPP4i in Glucose Homeostasis and Cardiorenal Syndrome
    Panda, Siva Prasad
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (02) : 179 - 187
  • [34] Network Meta-analysis of DPP-4i/SGLT2i Combination as Add-on to Metformin for T2DM
    Orme, Michelle Elaine
    Qin, Lei
    Varol, Nebibe
    Bell, Kelly
    Mukherjee, Jayanti
    DIABETES, 2016, 65 : A296 - A296
  • [35] SGLT2i use increases risk of postoperative diabetic ketoacidosis
    Reactions Weekly, 2022, 1931 (1) : 12 - 12
  • [36] SGLT2i and postglomerular vasodilation reply
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    KIDNEY INTERNATIONAL, 2020, 97 (04) : 806 - 806
  • [37] Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Dipeptidyl Peptidase 4 Inhibitor (DPP4i) as Initiator Therapy with Type 2 Diabetes on Cardiovascular Outcomes -A Systematic Review and Meta-analysis
    Shrestha, Abhigan B.
    Rajak, Kripa
    Tummala, Nayanika
    Maddineni, Gautam
    DIABETES, 2024, 73
  • [38] Association of SGLT2i on Amputation, Stent Placement, or Revascularization vs. DPP4-Cohort Study in Veterans
    Griffin, Katherine E.
    Snyder, Kathryn D.
    Javid, Amir Hossein
    Hackstadt, Amber J.
    Greevy, Robert A., Jr.
    Grijalva, Carlos G.
    Roumie, Christianne
    DIABETES, 2024, 73
  • [39] SGLT2i Use and the Risk of Nephrolithiasis in Patients with T2D
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary
    Mastrorilli, Julianna M.
    Wexler, Deborah J.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    DIABETES, 2022, 71
  • [40] Sacubitril/Valsartan and SGLT2i: a safe combination?
    Goena, C.
    Natividad, R.
    Rilo, I.
    Gomez, C.
    Perez De Nanclares, M.
    Lozano, A.
    Quintas, L.
    Zugazabeitia, G.
    Solla, I.
    Escolar, V.
    Rodriguez, I.
    Gil, P.
    Laskibar, A.
    Urreta, I.
    Romero, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 141 - 141
12345